Message from the Chair – This New Year brings great anticipation for progress in the treatment of melanoma and skin cancers, like cutaneous squamous cell carcinoma (cSCC). We have been anxiously awaiting provincial listings for adjuvant therapies for melanoma – in particular the adjuvant (for stage III fully resected patients), targeted therapy combination of Dabrafenib and Trametinib, and the adjuvant immunotherapies – Pembrolizumab and Nivolumab.
Melanoma Newsletter – Melanoma Patient Connection
INSIDE THIS ISSUE
Host an Event In Support Of Melanoma. From hockey and golf tournaments to birthday and dinner parties, there are many events that allow you to gather with friends and family, raise money for a noble cause, and rally around someone going through their cancer journey.